Lista de obras - Isabel Haro - Dominio Público Uruguay

A Langmuir monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with phospholipid membranes

artículo científico publicado en 2010

A Synthetic Glycopeptide of Substance P Analogue (SP6–11) with Enhanced NK-1 Receptor Specificity

artículo científico publicado en 1990

A cyclic GB virus C derived peptide with anti-HIV-1 activity targets the fusion peptide of HIV-1.

artículo científico publicado en 2014

Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.

artículo científico publicado en 2011

Analysis of the effect of a peptide sequence of the E2 protein (HGV/GBV-C) on the physicochemical properties of zwitterionic and negatively charged bilayers

artículo científico publicado en 2005

Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease?

artículo científico publicado en 2012

Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide

artículo científico publicado en 1995

Antibodies against β-fibrin synthetic peptides: a study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients

artículo científico publicado en 2011

Antibodies to Citrullinated Human Fibrinogen Synthetic Peptides in Diagnosing Rheumatoid Arthritis

artículo científico publicado en 2007

Antigenicity of chimeric and cyclic synthetic peptides based on nonstructural proteins of GBV-C/HGV.

artículo científico publicado en 2006

Application of a chimeric synthetic peptide in the development of a serologic method for the diagnosis of hepatitis G virus infection

artículo científico publicado en 2007

Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection

artículo científico publicado en 2009

Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology

artículo científico publicado en 2000

Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models

artículo científico publicado en 2009

Biophysical Investigations of GBV‐C E1 Peptides as Potential Inhibitors of HIV‐1 Fusion Peptide ⬇️

artículo científico publicado el 8 de septiembre de 2011

Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis

scientific article published on 28 June 2011

Characterization of a putative fusogenic sequence in the E2 hepatitis G virus protein

artículo científico publicado en 2005

Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays

artículo científico

Conformational behavior of the HAV-VP3(110-121) peptidic sequence and synthetic analogs in membrane environments studied by CD and computational methods

artículo científico publicado en 1998

Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery

artículo científico publicado en 2015

Contribution of the Tyr-1 in Plantaricin149a to disrupt phospholipid model membranes

artículo científico publicado en 2013

Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.

artículo científico publicado en 2016

Design and application of GB virus C (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection

artículo científico publicado en 2012

Design of synthetic peptidic constructs for the vaccine development against viral infections.

artículo científico publicado en 2004

Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis

article

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.

scientific article published on 02 September 2009

Diagnostic value of anti-GBV-C antibodies in HIV-infected patients

artículo científico publicado en 2011

Differences in secondary structure of HAV-synthetic peptides induced by the sequential order of T- and B-cell epitopes

artículo científico publicado en 2000

Different Approaches to Potentiate the Immune Response Induced by a 12-Mer Synthetic Peptide

artículo científico publicado en 2000

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis

artículo científico publicado en 2017

Editorial (Hot Topic:Rheumatoid Arthritis: Current Advances in Pathogenesis, Diagnosis and Therapy)

artículo científico publicado en 2013

Effect of E1(64-81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models.

artículo científico publicado en 2011

Effect of chain length of HAV-VP3 synthetic peptides on its interaction with biomembrane models

scientific article published on 01 December 2000

Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.

artículo científico publicado en 2010

Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide

artículo científico publicado en 2019

Effects of overlapping GB virus C/hepatitis G virus synthetic peptides on biomembrane models

artículo científico publicado en 2004

Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis.

artículo científico publicado en 2011

Fluorescence analysis of the interaction of two peptide sequences of hepatitis GB virus C with liposomes

artículo científico publicado en 2003

Fluorescence study of the dynamic interaction between E1(145-162) sequence of hepatitis GB virus C and liposomes.

artículo científico publicado en 2009

Fluorescence study on the interaction of a multiple antigenic peptide from hepatitis A virus with lipid vesicles.

artículo científico publicado en 2000

GB virus C (GBV-C) / hepatitis G virus (HGV): towards the design of synthetic peptides-based biosensors for immunodiagnosis of GBV-C/HGV infection

artículo científico publicado en 2003

Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant

artículo científico publicado en 2018

HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds

artículo científico

Hepatitis A Synthetic Peptide VP3(110–121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers

artículo científico publicado en 2000

Hydrophobic Laminin-Related Peptides: Synthesis and Surface Properties

artículo científico publicado en 2001

Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide

artículo científico publicado en 2020

In vitro activity and selectivity of glucosidic SP(66-11) analogues

artículo científico publicado en 1989

Influence of the saturation chain and head group charge of phospholipids in the interaction of hepatitis G virus synthetic peptides.

artículo científico publicado en 2005

Interaction of E2 and NS3 synthetic peptides of GB virus C/hepatitis G virus with model lipid membranes

artículo científico publicado en 2003

Interaction of GB virus C/hepatitis G virus synthetic peptides with lipid langmuir monolayers and large unilamellar vesicles

artículo científico publicado en 2009

Interaction of VP3(110–121) Peptide with Hepatocyte and Erythrocyte Membrane Models

artículo científico publicado en 1999

Interaction of opiate molecules with lipid monolayers and liposomes

artículo científico publicado en 1992

Interaction of synthetic peptides corresponding to hepatitis G virus (HGV/GBV-C) E2 structural protein with phospholipid vesicles

artículo científico publicado en 2005

Interaction of three beta-interferon domains with liposomes and monolayers as model membranes.

artículo científico publicado en 2004

Interaction of two overlapped synthetic peptides from GB virus C with charged mono and bilayers

artículo científico publicado en 2013

Interaction study of peptide from VP3 capsid protein of hepatitis A virus through monolayers and fluorescence spectroscopy

artículo científico publicado en 2001

Interfacial interactions of hydrophobic peptides with lipid bilayers

artículo científico publicado en 2002

Interfacial properties of a synthetic peptide derived from hepatitis G virus E2 protein: interaction with lipid monolayers

artículo científico publicado en 2006

Kinetic formulations for the reduction of ketomalonate by lactate dehydrogenase

artículo científico publicado en 1990

Lipid Vesicles Loaded with an HIV-1 Fusion Inhibitor Peptide as a Potential Microbicide

artículo científico publicado en 2020

Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity.

artículo científico publicado en 2016

Lipophilic derivatization of synthetic peptides belonging to NS3 and E2 proteins of GB virus-C (hepatitis G virus) and its effect on the interaction with model lipid membranes

artículo científico publicado en 2003

Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage

artículo científico publicado en 2007

Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design

artículo científico publicado en 2003

Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus

artículo científico publicado en 1999

Membrane fusion by an RGD-containing sequence from the core protein VP3 of hepatitis A virus and the RGA-analogue: implications for viral infection

artículo científico publicado en 2001

Miscibility and Langmuir Studies of the Interaction of E2 (279-298) Peptide Sequence of Hepatitis G Virus/GB Virus-C with Dipalmitoylphosphatidyl Choline and Dimiristoylphosphatidyl Choline Phospholipids.

artículo científico publicado en 2015

Modification of FP-HIV activity by peptide sequences of GB virus C: a biophysical approach.

artículo científico publicado en 2014

Oligonucleotide-peptide conjugates: solid-phase synthesis under acidic conditions and use in ELISA assays

artículo científico publicado en 2012

Peptide Amphiphilic-Based Supramolecular Structures with Anti-HIV-1 Activity

artículo científico publicado en 2021

Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides

article

Peptides and Liposomes: From Biophysical to Immunogenic Studies ⬇️

artículo científico publicado el 1 de noviembre de 2003

Perturbations induced by synthetic peptides from hepatitis G virus structural proteins in lipid model membranes: a fluorescent approach

artículo científico publicado en 2005

Phospholipid-model membrane interactions with branched polypeptide conjugates of a hepatitis A virus peptide epitope

artículo científico publicado en 2000

Physico-chemical characterization of liposomes with covalently attached hepatitis A VP3(101–121) synthetic peptide†

artículo científico publicado en 1998

Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: interaction with model membranes.

artículo científico publicado en 2012

Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?

artículo científico publicado en 2019

Spectroscopic analysis of the interaction of a peptide sequence of Hepatitis G virus with bilayers

artículo científico publicado en 2003

Structural Study of a New HIV-1 Entry Inhibitor and Interaction with the HIV-1 Fusion Peptide in Dodecylphosphocholine Micelles

artículo científico publicado en 2017

Study in mono and bilayers of the interaction of hepatitis G virus (GBV-C/HGV) synthetic antigen E2(99-118) with cell membrane phospholipids

artículo científico publicado en 2004

Study of Adsorption and Penetration of E2(279−298) Peptide into Langmuir Phospholipid Monolayers

artículo científico publicado en 2006

Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity

artículo científico publicado en 2011

Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition

artículo científico publicado en 2014

Synthesis and purification of two SP (6-11) analogues with enhanced selectivity for the NK-1 receptor ⬇️

artículo científico publicado el 1 de febrero de 1990

Synthesis of Overlapping Fibrin Citrullinated Peptides and their use for Diagnosing Rheumatoid Arthritis

artículo científico publicado en 2006

Synthesis of rgd containing peptides. Comparative study of their incorporation to the surface of 5-fluoruridine loaded liposomes.

artículo científico publicado en 2001

Synthesis ofO 1.5-(β-D-galactopyranosyl) [DMet2, Hyp5] enkephalin amide, a new highly potent analgesic enkephalin-related glycosyl peptide

artículo científico publicado en 1989

Synthesis, lipophilic derivatization and interaction with liposomes of HAV–VP3 (102–121) sequence by using spectroscopic techniques

artículo científico publicado en 1996

Synthetic peptides for the immunodiagnosis of human diseases.

artículo científico publicado en 2007

Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide

artículo científico publicado en 2009

The covalent coupling of HAV-VP3 (110-121) synthetic peptide to liposomes: physicochemical studies.

artículo científico publicado en 2004

The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis

artículo científico publicado en 2011

Updating the use of synthetic peptides as inhibitors of HIV-1 entry.

artículo científico publicado en 2014

Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection

artículo científico publicado en 2000

Lista de obras de Isabel Haro

A Langmuir monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with phospholipid membranes

A Synthetic Glycopeptide of Substance P Analogue (SP6–11) with Enhanced NK-1 Receptor Specificity

A cyclic GB virus C derived peptide with anti-HIV-1 activity targets the fusion peptide of HIV-1.

Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.

Analysis of the effect of a peptide sequence of the E2 protein (HGV/GBV-C) on the physicochemical properties of zwitterionic and negatively charged bilayers

Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease?

Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide

Antibodies against β-fibrin synthetic peptides: a study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients

Antibodies to Citrullinated Human Fibrinogen Synthetic Peptides in Diagnosing Rheumatoid Arthritis

Antigenicity of chimeric and cyclic synthetic peptides based on nonstructural proteins of GBV-C/HGV.

Application of a chimeric synthetic peptide in the development of a serologic method for the diagnosis of hepatitis G virus infection

Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection

Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology

Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models

Biophysical Investigations of GBV‐C E1 Peptides as Potential Inhibitors of HIV‐1 Fusion Peptide ⬇️

Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis

Characterization of a putative fusogenic sequence in the E2 hepatitis G virus protein

Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays

Conformational behavior of the HAV-VP3(110-121) peptidic sequence and synthetic analogs in membrane environments studied by CD and computational methods

Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery

Contribution of the Tyr-1 in Plantaricin149a to disrupt phospholipid model membranes

Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.

Design and application of GB virus C (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection

Design of synthetic peptidic constructs for the vaccine development against viral infections.

Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.

Diagnostic value of anti-GBV-C antibodies in HIV-infected patients

Differences in secondary structure of HAV-synthetic peptides induced by the sequential order of T- and B-cell epitopes

Different Approaches to Potentiate the Immune Response Induced by a 12-Mer Synthetic Peptide

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis

Editorial (Hot Topic:Rheumatoid Arthritis: Current Advances in Pathogenesis, Diagnosis and Therapy)

Effect of E1(64-81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models.

Effect of chain length of HAV-VP3 synthetic peptides on its interaction with biomembrane models

Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.

Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide

Effects of overlapping GB virus C/hepatitis G virus synthetic peptides on biomembrane models

Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis.

Fluorescence analysis of the interaction of two peptide sequences of hepatitis GB virus C with liposomes

Fluorescence study of the dynamic interaction between E1(145-162) sequence of hepatitis GB virus C and liposomes.

Fluorescence study on the interaction of a multiple antigenic peptide from hepatitis A virus with lipid vesicles.

GB virus C (GBV-C) / hepatitis G virus (HGV): towards the design of synthetic peptides-based biosensors for immunodiagnosis of GBV-C/HGV infection

Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant

HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds

Hepatitis A Synthetic Peptide VP3(110–121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers

Hydrophobic Laminin-Related Peptides: Synthesis and Surface Properties

Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide

In vitro activity and selectivity of glucosidic SP(66-11) analogues

Influence of the saturation chain and head group charge of phospholipids in the interaction of hepatitis G virus synthetic peptides.

Interaction of E2 and NS3 synthetic peptides of GB virus C/hepatitis G virus with model lipid membranes

Interaction of GB virus C/hepatitis G virus synthetic peptides with lipid langmuir monolayers and large unilamellar vesicles

Interaction of VP3(110–121) Peptide with Hepatocyte and Erythrocyte Membrane Models

Interaction of opiate molecules with lipid monolayers and liposomes

Interaction of synthetic peptides corresponding to hepatitis G virus (HGV/GBV-C) E2 structural protein with phospholipid vesicles

Interaction of three beta-interferon domains with liposomes and monolayers as model membranes.

Interaction of two overlapped synthetic peptides from GB virus C with charged mono and bilayers

Interaction study of peptide from VP3 capsid protein of hepatitis A virus through monolayers and fluorescence spectroscopy

Interfacial interactions of hydrophobic peptides with lipid bilayers

Interfacial properties of a synthetic peptide derived from hepatitis G virus E2 protein: interaction with lipid monolayers

Kinetic formulations for the reduction of ketomalonate by lactate dehydrogenase

Lipid Vesicles Loaded with an HIV-1 Fusion Inhibitor Peptide as a Potential Microbicide

Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity.

Lipophilic derivatization of synthetic peptides belonging to NS3 and E2 proteins of GB virus-C (hepatitis G virus) and its effect on the interaction with model lipid membranes

Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage

Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design

Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus

Membrane fusion by an RGD-containing sequence from the core protein VP3 of hepatitis A virus and the RGA-analogue: implications for viral infection

Miscibility and Langmuir Studies of the Interaction of E2 (279-298) Peptide Sequence of Hepatitis G Virus/GB Virus-C with Dipalmitoylphosphatidyl Choline and Dimiristoylphosphatidyl Choline Phospholipids.

Modification of FP-HIV activity by peptide sequences of GB virus C: a biophysical approach.

Oligonucleotide-peptide conjugates: solid-phase synthesis under acidic conditions and use in ELISA assays

Peptide Amphiphilic-Based Supramolecular Structures with Anti-HIV-1 Activity

Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides

Peptides and Liposomes: From Biophysical to Immunogenic Studies ⬇️

Perturbations induced by synthetic peptides from hepatitis G virus structural proteins in lipid model membranes: a fluorescent approach

Phospholipid-model membrane interactions with branched polypeptide conjugates of a hepatitis A virus peptide epitope

Physico-chemical characterization of liposomes with covalently attached hepatitis A VP3(101–121) synthetic peptide†

Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: interaction with model membranes.

Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?

Spectroscopic analysis of the interaction of a peptide sequence of Hepatitis G virus with bilayers

Structural Study of a New HIV-1 Entry Inhibitor and Interaction with the HIV-1 Fusion Peptide in Dodecylphosphocholine Micelles